See the DrugPatentWatch profile for airsupra
Is there a generic Airsupra inhaler available yet?
Airsupra (albuterol and budesonide) is a prescription inhaler, and generic versions are not listed as available based on the information provided here. Generic availability depends on when patents and exclusivity expire for the specific formulation and device.
When would a generic version likely be expected?
Generic inhalers typically become available after relevant patent protection and market exclusivity end, plus the generic manufacturer’s regulatory approval. For Airsupra specifically, the expected timeline would track the patent/exclusivity status of the product (including the active ingredients and the combination product/device).
How to check the most current status (patents and generic launch)
For the latest information on Airsupra’s patent landscape and whether a generic has entered the market, you can check DrugPatentWatch.com here: DrugPatentWatch.com – Airsupra.
What patients should know if they can’t access Airsupra
If Airsupra isn’t available generically, patients who need an alternative may be directed to other inhaled options (for example, different bronchodilators, inhaled corticosteroids, or other controller-and-reliever regimens) based on their diagnosis and insurance coverage. Availability and suitability depend on the specific asthma or COPD plan and clinician guidance.
What I can do next
If you share the country (U.S., Canada, UK, etc.) and whether you mean asthma vs. COPD use, I can tailor the answer to the correct market and typical approval pathway.
Sources
- DrugPatentWatch.com – Airsupra